It is a rare scenario where long-term interest rates suddenly fall below short-term interest rates.Real Estateread more
Arturo Estrella has a message for recession naysayers: It could hit sooner than you think.Marketsread more
Fed Chairman Jerome Powell faces the tough challenge of presenting a unified voice on Fed policy from the most divided Fed in years.Market Insiderread more
Overstock CEO Partick Byrne has resigned from the e-commerce company after making comments about his role in the "deep state."Technologyread more
It was the third trigger of the recession indicator in less than two weeks.Bondsread more
Automakers are trying to deal with President Trump's efforts to roll back Obama-era fuel efficiency rules.Autosread more
Mark Zuckerberg has been on a selling spree in August and has unloaded $526 million worth of stock this year.Technologyread more
Palantir CEO Alex Karp said billionaire investor Peter Thiel is right to question Google's decision to work in China, while abandoning military contracts in the US.Technologyread more
These are the stocks posting the largest moves midday.Market Insiderread more
U.S. manufacturer growth slowed to the lowest level in almost 10 years in August, the latest sign that the trade war may be exacerbating the economic slowdown.Marketsread more
L Brands shares fell by as much as 12% at one point, touching $17.61 — a price not seen since December 2009.Retailread more
The report, published in the New York Post, cited unnamed sources, and said any approval would come with conditions.
The deal hopes to combine the first and third largest drugstore operators. Some have said that if it gets regulatory approval, it could further escalate the competition between Walgreens and CVS Health.
The regulator's chief concern has been the negotiating power the combined company will have with pharmacy benefit managers, who negotiate prices with drug manufacturers for pharmacies. However, the Post said the chief executive of the number one PBM, Express Scripts CEO Tim Wentworth, said Thursday that he supported the deal.
There will still be, post-merger, plenty of competition in retail, Wentworth told the Post. He added there are questions about whether any of the sizable pharmacy benefit managers will object.
Walgreen is expected to announce in a few days the beginning of a process to divest stores in regions where the chains may have too much overlap, a source close to the situation told the Post.
Shares of both Walgreens and Rite Aid both traded in heavier-than-usual volume Friday. Walgreens shares closed up 4.4 percent with nearly 10.8 million shares trading hands, compared with its 30-day average volume of 4.3 million.
WAB 2016 Chart
Rite Aid gained 3.4 percent on volume of nearly 43 million shares, more than double its 30-day average volume of 14.1 million shares.
RAD 2016 Chart